IC
JSPR icon

IEQ Capital’s Jasper Therapeutics JSPR Stock Holding History

IEQ Capital’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7K Sell
13,538
-37,890
-74% -$28.4K ﹤0.01% 2010
2026
Q1 		$45.1K Buy
51,428
+1,000
+2% +$1.39K ﹤0.01% 1847
2025
Q4 		$92.3K Buy
50,428
+2,310
+5% +$4.64K ﹤0.01% 1770
2025
Q3 		$115K Buy
+48,118
New +$146K ﹤0.01% 1751
2024
Q1 		– Sell
-5,450
Closed -$43K – 991
2023
Q4 		$43K Buy
+5,450
New +$36.6K ﹤0.01% 911

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's JSPR Position: Q2 2026 in Review

IEQ Capital reduced its Jasper Therapeutics (JSPR) stake by 74% in Q2 2026, selling an estimated $28.4K and leaving 13,538 shares worth $5.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

IEQ Capital first reported a position in JSPR in Q4 2023 and has held it in 5 quarters since. The position peaked at $115K in Q3 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • IEQ Capital held 13,538 shares of Jasper Therapeutics worth $5.7K as of Q2 2026.
  • IEQ Capital sold 37,890 Jasper Therapeutics shares in Q2 2026, an estimated $28.4K.
  • Jasper Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #2010 holding.
  • IEQ Capital first reported a position in Jasper Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • IEQ Capital's Jasper Therapeutics position peaked at $115K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.